How AI and CDMO/CRO Integration is Key to the Future of Drug Development
The next era of drug development will be connected, data-driven and centered on patient impact
False
The next era of drug development will be connected, data-driven and centered on patient impact
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 22, 2026
5 min read
Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner
October 22, 2026
5 min read
Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.
October 15, 2026
8 min read
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
October 7, 2026
1 min read
Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization
False
Affiliations:
Specialties:
Areas of Expertise: